Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Article(5)
Publisher
The Lancet(2)
Journal of the American Heart Association(1)
The Lancet Diabetes and Endocrinology(1)
The Lancet Global Health(1)
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study
ArticleAbstract: Background: Data are scarce on the availability and affordability of essential medicines for diabetePalabras claves:Autores:Alhabib K.F., Avezum A.J., Cheng X., Chifamba J., Chow C.K., Corsi D.J., Dagenais G.R., Dans A.M., Egbujie B.A., Gerstein H.C., Gupta R., Hu W., Iqbal R., Islam S., Keskinler M.V., Khatib R., Kruger L., Kumar R., Lanas F.T., Lear S.A., Mckee M., Mohammadifard N., Mohan V., Mony P.K., Noorhassim I., Orlandini A., PATRICIO LOPEZ -JARAMILLO, Ramasundarahettige C., Rangarajan S., Rosengren A., Teo K.K., Vijayakumar K., Wei L., Yeates K.E., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M., Zatońska K., Zhou Y.Fuentes:googlescopusEffects of lipid-lowering and antihypertensive treatments in addition to healthy lifestyles in primary prevention: An analysis of the HOPE-3 trial
ArticleAbstract: Background-It is not clear whether the effects of lipid-lowering or antihypertensive medications arePalabras claves:Antihypertensive agent, statinAutores:Avezum A.J., Bogaty P.M., Bosch J.J., Dagenais G.R., Dehghan M., Held C., Jansky P., Jung H., Keltai M., Leiter L.A., Lonn E.M., PATRICIO LOPEZ -JARAMILLO, Toff W.D., Yusuf S.Fuentes:googlescopusInequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
ArticleAbstract: Background: There is little evidence on the use of secondary prevention medicines for cardiovascularPalabras claves:Autores:Alhabib K.F., Avezum A.J., Bai X., Chifamba J., Chow C.K., Corsi D.J., Dagenais G.R., Dans A.M., DIaz R., Erbakan A.N., Iqbal R., Kelishadi R., Khatib R., Lanas F., Lear S.A., Li W., Liu J., Mckee M., Mohan V., Monsef N., Mony P.K., Murphy A., Noorhassim I., O'Donnell O., Palafox B., PATRICIO LOPEZ -JARAMILLO, Perel P., Puoane T., Rangarajan S., Rosengren A., Schutte A.E., Sintaha M., Stuckler D., Teo K.K., Wielgosz A., Yeates K.E., Yin L., Yusoff K., Yusuf S., Zatońska K.Fuentes:googlescopusUrinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study
ArticleAbstract: Background: WHO recommends that populations consume less than 2 g/day sodium as a preventive measurePalabras claves:Autores:Ah S.T.L., Alhabib K.F., Avezum A.J., Chifamba J., Dagenais G.R., Dans A.M., DIaz R., Gulec S., Iqbal R., Khatib R., Kruger L., Lanas F.T., Lear S.A., McQueen M.J., Mente A., Mohammadifard N., Mony P.K., Noorhassim I., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rosengren A., Szuba A., Teo K.K., Tsolekile L.P., Wei L., Wielgosz A., Yeates K.E., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusRivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
ArticleAbstract: Background: Coronary artery disease is a major cause of morbidity and mortality worldwide, and is aPalabras claves:Autores:ABIB E., ABRANTES J.A., AHUAD GUERRERO R.A., ALBISU DI GENNERO J.P., ALVAREZ M., Anand S.S., Avezum A.J., Barbieri M., BARTOLACCI I.P., Berkowitz S.D., Bhatt D.L., BORDONAVA A.P., Bosch J.J., Branch K.R.H., CACCAVO A., CARDONA M., CARTASEGNA L.U.I.S., Chacón C., Connolly S.J., Cook-Bruns N., COSTABEL J.P., CUADRADO J., Cuneo C.A., Dagenais G.R., Dans A.M., DEBONNAIRE P., DRAN R.D., DUJARDIN K.A.R.L., Dyal L., ECTOR B.A.V.O., Eikelboom J.W., ELEGEERT I.V.A.N., Felix Camilo, FERRE PACORA F.A., Fox K.A.A., GARCIA DURAN R.O., GARRIDO M., Gomez Vilamajo O., GONZALEZ COLASO P.D.C., GRINFELD D., Guzik T.J., GUZMAN L.U.I.S., Ha J.W., HASBANI E., HERNANDES M., HOFFER E., HOMINAL M.A., Hori M., HRABAR A., IBANEZ SAGGIA L.M., INDIO DO BRASIL C., Ingaramo A., Keltai K., Lanas F., LEROY J.E.A.N., LITVAK BRUNO M.R., Liu L., Lonn E.M., LUCIARDI H.L., LUQUEZ H.U.G.O., MACIN S.M., MACKINNON I.J., MAFFEI L.E., Maggioni A.P., Maia L.N., MAJUL C.R., MANENTI E., Metsarinne K.P., Montaña O., NANI S., Novaretto L., O’Donnell M., Parkhomenko A.N., PELAGAGGE M.J., Precoma D.B., RECH R., Reis G., ROSSI DOS SANTOS F., ROSSI P., SALA J., SARAIVA J.O.S.E., SARJANOVICH R.J., SCHIAVI L.B., SCHROE H., SCHYGIEL P.O., Torp-Pedersen C., VAN DE BORNE P., VAN DEN HEUVEL P.A.U.L., Varigos J.D., VENSENTINI N., Verhamme P.B., VICO M., VITA N.A., VOGEL D., VRANCKX P., Widimsky P., Yusoff K., Yusuf S., ZAIDMAN C., ZIMMERMANN S.L.Fuentes:googlescopus